cookies-img
We use third-party cookies to provide support. By continuing to browse this website, you accept our privacy policy.
close-icon
Verve Therapeutics Inc
13 own
5 watching
Current Price
$5.28
$-0.01
(-0.19%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Market Capitalization
Market Capitalization
1,088.17M
52-Week High
52-Week High
21.04000
52-Week Low
52-Week Low
4.90000
Average Volume
Average Volume
1.05M
Dividend Yield
Dividend Yield
--
P/E Ratio
P/E Ratio
--
iconMarket Capitalization1,088.17M
icon52-Week High21.04000
icon52-Week Low4.90000
iconAverage Volume1.05M
iconDividend Yield--
iconP/E Ratio--
What does the Verve Therapeutics Inc do?
Verve Therapeutics, Inc., a genetic medicines company, engages in developing gene editing medicines for patients to treat cardiovascular diseases. Its lead product candidate is VERVE-101, a single-course gene editing treatment that permanently turns off the PCSK9 gene in the liver. The company also engages in the development of ANGPTL3 program to permanently turn off the ANGPTL3 gene in the liver. It has a collaboration and license agreement with Beam Therapeutics Inc.; a development and option agreement with Acuitas Therapeutics, Inc.; and a Cas9 license agreement with The Broad Institute and the President and Fellows of Harvard College. The company was formerly known as Endcadia, Inc. and changed its name to Verve Therapeutics, Inc. in January 2019. Verve Therapeutics, Inc. was incorporated in 2018 and is headquartered in Cambridge, Massachusetts.
Read More
How much money does Verve Therapeutics Inc make?
News & Events about Verve Therapeutics Inc.
Zolmax
1 year ago
Verve Therapeutics, Inc. (NASDAQ:VERV Get Rating) gapped up prior to trading on Thursday . The stock had previously closed at $17.10, but opened at $17.51. Verve Therapeutics shares last traded at $18.30, with a volume of 160,713 shares changing hands. Analyst Ratings Changes Several equities ...
PR Newswire
1 year ago
Thinking about buying stock in Bentley Systems, MicroStrategy, Icahn Enterprises, Verve Therapeutics, or Bilibili? Thinking about buying stock in Bentley Systems, MicroStrategy, Icahn Enterprises, Verve Therapeutics, or Bilibili? PR Newswire NEW YORK, June 15, 2023 NEW YORK, June 15, 2023...
Ticker Report
1 year ago
Sumitomo Mitsui Trust Holdings Inc. boosted its holdings in Verve Therapeutics, Inc. (NASDAQ:VERV Get Rating) by 58.4% during the 4th quarter, according to its most recent disclosure with the Securities Exchange Commission. The institutional investor owned 1,228,447 shares of the ...
Globe Newswire
1 year ago
VERVE-201 Preclinical Data Supports Advancement of Drug Candidate Toward Clinical Development for Homozygous Familial Hypercholesterolemia, with Initiation of Clinical Trial Anticipated in 2024 Data to be Presented During an Oral Presentation at the2023 American College of Cardiologys Annual ...
PR Newswire
1 year ago
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Verve Therapeutics, Inc. - VERV SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Verve Therapeutics, Inc. - VERV PR Newswire NEW YORK, Jan. 4, 2023 NEW YORK, Jan. 4, 2023...
Frequently Asked Questions
Frequently Asked Questions
What is Verve Therapeutics Inc share price today?
plus_minus_icon
Can Indians buy Verve Therapeutics Inc shares?
plus_minus_icon
How can I buy Verve Therapeutics Inc shares from India?
plus_minus_icon
Can Fractional shares of Verve Therapeutics Inc be purchased?
plus_minus_icon
What are the documents required to start investing in Verve Therapeutics Inc stocks?
plus_minus_icon
What is today’s traded volume of Verve Therapeutics Inc?
plus_minus_icon
What is today’s market capitalisation of Verve Therapeutics Inc?
plus_minus_icon
What is the 52-Week High and Low Range of Verve Therapeutics Inc?
plus_minus_icon
What percentage is Verve Therapeutics Inc down from its 52-Week High?
plus_minus_icon
What percentage is Verve Therapeutics Inc up from its 52-Week Low?
plus_minus_icon
Current Price
$5.28
$-0.01
(-0.19%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Get Started with as little as $1.00